345 Park Avenue South

Blue

News & Insights

Your Home in NYC

Cure Founders Pass Membership Benefits 03 Tab Bar Image

Dark Blue

Apply for Membership

Where Healthcare Innovators Connect

Magenta

Attend An Event

Accelerating Advances in Health

Green

About

Contact us

### About

Susan Schulz is a content, communications and marketing consultant with more than 15 years’ experience in advising clients on overall strategy, thought leadership, content creation, digital marketing and corporate communications.

### Experience 

For more than a decade, Schulz had the privilege of working closely with scientists in academia, government, and healthcare, delving into the heart of their passions and motivations. She brings a unique blend of journalistic expertise and empathetic insight to help them unravel the narratives within their work, making it not only comprehensible but captivating. Shining a deserved spotlight on the stories of scientists and their work is what Schulz loves to do.
Prior to launching her consulting firm, TheScientistWhisperer.com, Schulz served as VP of Marketing for the Muscular Dystrophy Association, as the Marketing Director for The New York Academy of Sciences, and as an “Advocate for Curiosity” for the American Committee for the Weizmann Institute of Science. She also spent a successful 20 years in magazines, holding exciting editorial and leadership roles at respected brands including Cosmopolitan and Good Housekeeping.

### Education

Schulz is a graduate of Loyola University Maryland and hold a certificate in Digital Marketing Strategies from Northwestern University - Kellogg School of Management.

Contributing Writer

Former FDA Commissioner Robert Califf, MD, outlines the biggest roadblocks facing biotech today. From trust and primary care gaps to regulatory instability—and where innovation is most needed.

Headshot Robert Califf MD

The Hard Truth About Biotech’s Future, According to Former FDA Chief Robert Califf

The final day of Cure's X Factor Summit featured six panels that ranged from breakthrough innovations to the momentum in women's health.

thumbnail_xfactor_day2_1200x675

4 Key Themes From Day 2 of Cure's X Factor Healthcare Innovation Summit

Here's what you missed from the first full day of Cure's X Factor Summit, where leaders from science, technology, and industry discussed how trust, patient empowerment, technology, and U.S. leadership are shaping the next era of innovation.

The X-Factor Healthcare Innovation Summit Day 1 Recap

5 Key Themes From Day 1 of Cure's X Factor Healthcare Innovation Summit

The entrepreneurs in this inaugural cohort stood out for pairing strong clinical or operational validation with the potential to scale and pilot their techology globally.

Meet the 15 Startups Joining Cure’s Middle East Health Accelerator Image

Meet the 15 Startups Joining Cure’s Middle East Health Accelerator

Cell and gene therapies (CGTs) contain hold transformative potential for  patients with rare diseases, yet their high manufacturing costs keep them out of reach  for the most, a problem that BioCurie is working to solve.

Thumbnail Irene Rombel C3 Summit Winner Alternate - Image

WINNER King Faisal & Davos of Healthcare Innovation Challenge Alternate - Image

BioCurie Wins 2025 King Faisal & Davos of Healthcare Innovation Challenge 

Five finalists from around the globe are pitching their transformative healthcare technologies, which span personalized cancer therapies, postpartum depression diagnostics, AI-driven cell and gene therapy manufacturing, hospital workflow systems, and next-generation gene editing.

Meet the Five Finalists in the King Faisal & Davos of Healthcare Innovation Challenge 

The BioVenture eLab, part of Weill Cornell Medicine Enterprise Innovation, equips innovators with business expertise, funding pathways, and investor connections to accelerate the translation of ideas to the marketplace.

Turning Research into Healthcare Startups: Weill Cornell Medicine’s BioVenture eLab

The Gates Foundation’s $2.5 billion pledge is historic, but founders say it’s only a starting point. Here’s how they want the money to be spent, and why more bold action is still needed.

Women’s Health Founders React to Gates Foundation $2.5 Billion Pledge Image

Women’s Health Founders React to Gates Foundation $2.5 Billion Pledge

Scaling a startup is more than just growth. Founders from G9 Ventures, Evvy, Inflect Health, and Kindbody offer six tips to preserve trust, brand, and purpose as your company gets larger.

Scaling Smart: How to Grow Women’s Health Startups 

Founders behind Teal Health, Proov, Sunny, and Bloomlife reveal lessons from their FDA experiences, from unexpected reclassifications to trial redesigns to funding gaps.

How MedTech Startups Navigate the FDA: Lessons from Women’s Health Innovators

When VCs say no, founders are tapping alternative sources, from academic accelerators and angel investors to strategic industry partnerships and mission-aligned family offices, to bring solutions to market.


Beyond VC: 6 Ways to Fund Your Healthcare Startup

Founders behind Elektra Health, Frame Fertility, Gabbi, and OOVA share how trial, error and trust shaped their GTM journeys.

4 Women’s Health Entrepreneurs Reveal Go-to-Market Strategies image

4 Women’s Health Entrepreneurs Reveal Go-to-Market Strategies

Entrepreneurs Jenny Carillo, Roya Pakzad, and Mike Satow advise on how to healthcare companies can prepare for acquisitions, from bankers and buyers to IP and partnerships. 

How to Exit Smart:  7 Mistakes Healthcare Founders Should Avoid 

Jennifer Celio Li of Samsung, Mika Miyake of Garmin Health, and Nichole Young-Lin of Google share how women’s health startups can collaborate with Big Tech.

How to Win Over Big Tech: Partnership Playbook for FemTech Founders

How can improving care options lead to unlocking profitability? Women’s health entrepreneurs from Daré Biosciences, Organon, and Willow offered insights at the 2025 SiS New York Conference.

Thumbnail SiS video Seema Kumar Sabrina Johnson Dare

6 Ways to Make Women’s Health Profitable

XSeed Award winner Chandrabali Ghose, PhD, a pioneer of novel antibiotic research, now innovates Cystic Fibrosis solutions and offers funding insights for startups.

How Chandrabali Ghose Drives Therapeutic Innovation

Angel investor and pharma industry executive-turned-consultant Shwen Gwee has worked with startups for more than 15 years, garnering insights for biopharma entrepreneurs.

5 Startup Funding Tips from Angel Investor Shwen Gwee

As artificial intelligence changes health, environmental tech and robotics, experts predict longer lives, cleaner air and humanoids

How will AI Transform the Way We Live and Breathe

Despite women making up more than half of the population, advancements in women’s health remain overlooked and underfunded. Here’s why.

thumbnail_boardroom_woman_business

5 Things Needed for Femtech to Flourish

Working with his Einstein colleagues, Nicholas Sibinga, MD, earned a 2022 XSeed Award for identifying a protein pathway with potential to help prevent devastating neurodegenerative diseases including multiple sclerosis and ALS.

Nicholas Sibinga, MD

New Approach for Neurodegenerative Diseases like MS and ALS  

What obstacles must be overcome for disruptive tools like AI, VR and robotics to reshape healthcare as we know it? Daniel Kraft, MD, explains.

Unlocking the Future of Healthcare: How AI, VR, and Robotics will Reshape Medicine

Arne Gennerich, PhD, Professor of Biochemistry at the Albert Einstein College of Medicine and a 2022 XSeed Award winner, is racing to develop a treatment for patients with rare genetic neurological disorders known as KAND. 

xseed-past-winner-arne_gennerich

KIF1A Gene Research Advances Rare Neurological Disorder Treatment

XSeed Award winner Andras Fiser, PhD, is working to speed detection of antibiotic-resistant bacteria and selection of their best treatment to save lives.  

XSeed Past Winner Andras Fiser

The Race to Identify Treatments to Fight SuperBugs

Five science and industry experts shared their predictions during #GenAI4Pharma NYC on how AI will transform life science research to save time, money — and lives. 

Near-Future Promises for Healthcare AI, According to 5 Experts Image

Near-Future Promises for Healthcare AI, According to 5 Experts

With the help of a 2023 XSeed Award, Rohini Kavlakuntla, MSc, and her two graduate school buddies are advancing the work of their startup Helex to make genetic medicine accessible and affordable for those with debilitating kidney diseases.

xseed-past-winner-rohini_kalvakuntla

From Friends to Founders: On a Mission to Combat Kidney Disease

Jonathan Lai, PhD, is developing vaccine prototypes to prepare for or prevent future pandemics, with support of a 2021 XSeed Award.

building-a-defense-against-future-global-pandemics

Building a Defense Against Future Global Pandemics

Neuropharmacology and drug delivery expert Ashiwel Undieh, PhD, shares how his 2021 XSeed Award accelerated and enables his research. 

thumbnail-ashiwel-undieh

One Unrestricted Grant Yields Multiple Opportunities for Health

Nigerian-born Chidiebere Awah, MD, PhD, CEO of UTR Therapeutics Inc., has created a technology with potential to not only take on aggressive cancers, but also Alzheimer’s disease, metabolic diseases and more.

Chidiebere Uzodinma Awah, MD, PhD, CEO of UTR Therapeutics Inc.

How Funding and Mentorship Forged a New Path to Fight Cancer

A trusted source of cutting-edge in-depth journalism coveing the ever-evolving world of science, SciAm discusses reporting on science innovation.

Jeremy Abbate

Scientific American Publisher Shares How Reporting Must Evolve

Gillian Sandler is a life sciences investor who funds health tech companies with potential to help millions. But she began with a simple desire:  Find a treatment for her sister’s autoimmune disease.

How a Passionate Investor Battles Auto-Immunity

How a Passionate Investor Battles Autoimmunity Disease

How can societal perceptions of people who are neurodiverse change to enable them to fully their potential?

Embracing Neurodiversity to Drive Access & Equity. no 2

Thinking Different About Neurodiversity 

 Jeremy Abbate, of "Scientific American" weighs in on the why communicating science more challenging than ever.

Trust & Accuracy: Science Communication & Storytelling in the 21st Century

Five Challenges Facing Science Journalists in the Post-COVID World

Nathan Friedman and the New York City-based nonprofit, Understood.org, seek to end the stigmas surrounding neurodiversity.

Embracing Neurodiversity to Drive Access & Equity v2

Five Facts about Neurodiversity You Probably Didn’t Know

When he was a little boy, Collins “Collogh” Oghor lost his aunt to kidney failure, and now, having earned an MD, MBA, and MPH, he has developed an AI solution to help healthcare providers battle this devastating — and preventable — disease.

Cure Xchange Challenge Finalist Collogh Cares logo

Collogh Cares Logo

Spotlight On: Collogh Cares Co-founder Collins Oghor, MD, MBA, MPH

Grant Mitchell, MD, MBA, and his co-founder are on a mission to use AI to match drugs already on the market with diseases that currently have no cure.  

Spotlight On_Grant_Mitchell_Image

Spotlight On: Grant Mitchell, MD, MBA, CEO and Co-founder of Every Cure

As an ER nurse, Kwamane Liddell, JD, MHA, BSN, encountered many low-income families whose language barriers kept them from taking advantage of nutritious food assistance programs. He realized AI could help these families successfully access not only nutrition but also medicine, housing, and even health insurance.

ThriveLink Logo

Spotlight On: Kwamane Liddell, JD, MHA, Co-founder ThriveLink (formerly Nutrible) 

With her co-founder Professor Richard Braatz, PhD, of MIT, Irene Rombel, PhD, MBA, aims to make innovative cell and gene therapies more accessible for people living with devastating rare diseases by overcoming the manufacturing dilemmas plaguing these treatments.

Cure Xchange Challenge Finalist BioCurie logo

BioCurie Logo

Spotlight On: Irene Rombel, PhD, MBA, Co-founder, BioCurie

Driven to help people in marginalized communities get the healthcare they deserve, Jonathan Govette and his co-founders developed an AI solution for identifying people at high risk for lung cancer, so they can get treated early — saving both money and lives.

Cure Xchange Challenge Finalist Oatmeal Health logo

Oatmeal Health Logo

Spotlight On: Oatmeal Health Co-founder Jonathan Govette

As a young radiologist in Casablanca, Morocco, Saad Slimani, MD, MS, noticed an opportunity to use AI to provide all pregnant women, regardless of socioeconomic status, with access to a simple procedure that could save their lives as well as the lives of their babies.

Cure Xchange Challenge Finalist Deepecho logo

Deepecho Logo

Spotlight On: Saad Slimani, MD, MS,  Co-founder of Deepecho

Through his company Allagi.ai, Alex Gavryushkin, PhD, is using AI to streamline a time-consuming process for oncologists, allowing them to devise more effective treatment plans for patients, including those with rare and hard-to-treat cancers.

Cure Xchange Challenge Finalist Allagi.ai logo

Allagi.ai

Spotlight On: Alex Gavryushkin, Founder of Allagi.ai

AI engineer Robhy Bustami grew up in a family of obstetricians. His knowledge of the challenges around access to quality maternal medicine led him to develop an ultrasound technology solution poised to improve the health of families in underserved communities worldwide.

Cure Xchange Challenge Finalist Biotics.ai logo

BioticAI

Spotlight On: Robhy Bustami, Co-founder of BioticsAI

After the sudden death of his older brother from hypertension, Peter Njongwe launched a company that marries cutting-edge AI technology with friendly neighborhood barbershops. It’s an innovative approach to getting hesitant populations to embrace the healthcare they need.

Cure Xchange Challenge Finalist Oben Health logo

Racing to Cures: The Cure U.S.-China Biotech Competitiveness Scorecard

What Makes an Institution Innovative? A Cure Original Report

Your Home in NYC

Where Healthcare Innovators Connect

Accelerating Advances in Health

Susan Schulz

42 Articles by Susan Schulz